Survival After Adjuvant Chemotherapy in Completely Resected N1 Non-Small Cell Lung Cancer

被引：0
|
作者：
Wang, E. [1 ]
Bourdages-Pageau, E. [1 ]
Gagnon, H. [1 ]
Labbe, C. [2 ]
Tremblay, L. [1 ]
Ugalde, P. [1 ]
机构：
[1] Inst Univ Cardiol & Pneumol Quebec, Thorac Oncol Surg, Quebec City, PQ, Canada
[2] Quebec Heart & Lung Inst Res Ctr, Quebec City, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
adjuvant chemotherapy; Non-Small Cell Lung Cancer;
D O I：
10.1016/j.jtho.2019.08.1333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.18-17
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [21] Feasibility Study of Adjuvant Chemotherapy of S-1 and Carboplatin for Completely Resected Non-Small Cell Lung Cancer
    Komazaki, Yoshitoshi
    Sakashita, Hiroyuki
    Furuiye, Masashi
    Fujie, Toshihide
    Tamaoka, Meiyo
    Sumi, Yuki
    Miyazaki, Yasunari
    Kojima, Katsuo
    Jin, Yasuto
    Inase, Naohiko
    CHEMOTHERAPY, 2013, 59 (01) : 35 - 41
  • [22] Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Greco, FA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 689 - 689
  • [23] Prediction of disease-free survival of N1/2 non-small cell lung cancer after adjuvant chemotherapy by the biomarker RPMB
    An, Ning
    Yang, Xue
    HELIYON, 2023, 9 (07)
  • [24] Identification of risk groups in patients with completely resected N1 non-small cell lung carcinoma
    Sawyer, TE
    Bonner, JA
    Gould, PJ
    Foote, RL
    Deschamps, C
    Trastek, VF
    Pairolero, PC
    Allen, MS
    Lange, CM
    Li, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 317 - 317
  • [25] Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    ANNALS OF THORACIC SURGERY, 2007, 84 (01): : 182 - 190
  • [26] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [27] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Shuji Murakami
    Haruhiro Saito
    Tetsuro Kondo
    Hiroyuki Ito
    Fumihiro Oshita
    Kouzo Yamada
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 81 - 87
  • [28] Split-dose Cisplatin and Vinorelbine as Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer
    Hirai, Fumihiko
    Seto, Takashi
    Shimokawa, Mototsugu
    Inamasu, Eiko
    Toyozawa, Ryo
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (02) : 927 - 931
  • [29] Review of practice patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer (NSCLC)
    Visbal, A
    Kassam, F
    Johnston, M
    Feld, R
    Shepherd, F
    Darling, G
    Keshavjee, S
    Pierre, A
    Waddell, T
    Leighl, N
    LUNG CANCER, 2005, 49 : S97 - S97
  • [30] Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
    Murakami, Shuji
    Saito, Haruhiro
    Kondo, Tetsuro
    Ito, Hiroyuki
    Oshita, Fumihiro
    Yamada, Kouzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 81 - 87
12345